Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Dreyling

Showing results (151-160 of 336) with videos related to

Pageof 34
Sort By:
Blood Advances|April 4, 2019
Impact of age on clinical risk scores in follicular lymphomaStefan Alig, Vindi Jurinovic, Alessandro Pastore, et al.
Journal of the National Cancer Institute|May 2, 2007
Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysisHolger Schulz, Julia F Bohlius, Sven Trelle, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 13, 2010
Optimal use of bendamustine in chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma: treatment recommendations from an international consensus panelBruce D Cheson, Clemens-Martin Wendtner, Angelika Pieper, et al.
Haematologica|April 2, 2008
Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinationsSebastian Böttcher, Matthias Ritgen, Sebastian Buske, et al.
Haematologica|November 17, 2018
Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysisSimon Rule, Martin Dreyling, Andre Goy, et al.
Cancers|November 14, 2023
PTCY-Based Haploidentical Donor Transplantation versus HLA-Matched Related and Unrelated Donor Transplantations in Patients with Refractory or Relapsed Lymphoma-A Matched-Pair AnalysisSarah Haebe, Alessia Fraccaroli, Elena Stauffer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 2, 2018
Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study GroupVindi Jurinovic, Bernd Metzner, Michael Pfreundschuh, et al.
Blood|October 24, 2002
Genetic analysis of de novo CD5+ diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+ progenitor B cellTiemo Katzenberger, Andreas Lohr, Stephan Schwarz, et al.
Journal of Hematology & Oncology|October 17, 2019
APRIL and BAFF: novel biomarkers for central nervous system lymphomaMatthias Mulazzani, Marion Huber, Sabine Borchard, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 26, 2018
Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin LymphomasBruce D Cheson, Susan O'Brien, Michael S Ewer, et al.
Pageof 34

Showing results (151-160 of 336) with videos related to

Sort By:
Pageof 34
Blood Advances|April 4, 2019
Impact of age on clinical risk scores in follicular lymphomaStefan Alig, Vindi Jurinovic, Alessandro Pastore, et al.
Journal of the National Cancer Institute|May 2, 2007
Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysisHolger Schulz, Julia F Bohlius, Sven Trelle, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 13, 2010
Optimal use of bendamustine in chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma: treatment recommendations from an international consensus panelBruce D Cheson, Clemens-Martin Wendtner, Angelika Pieper, et al.
Haematologica|April 2, 2008
Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinationsSebastian Böttcher, Matthias Ritgen, Sebastian Buske, et al.
Haematologica|November 17, 2018
Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysisSimon Rule, Martin Dreyling, Andre Goy, et al.
Cancers|November 14, 2023
PTCY-Based Haploidentical Donor Transplantation versus HLA-Matched Related and Unrelated Donor Transplantations in Patients with Refractory or Relapsed Lymphoma-A Matched-Pair AnalysisSarah Haebe, Alessia Fraccaroli, Elena Stauffer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 2, 2018
Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study GroupVindi Jurinovic, Bernd Metzner, Michael Pfreundschuh, et al.
Blood|October 24, 2002
Genetic analysis of de novo CD5+ diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+ progenitor B cellTiemo Katzenberger, Andreas Lohr, Stephan Schwarz, et al.
Journal of Hematology & Oncology|October 17, 2019
APRIL and BAFF: novel biomarkers for central nervous system lymphomaMatthias Mulazzani, Marion Huber, Sabine Borchard, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 26, 2018
Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin LymphomasBruce D Cheson, Susan O'Brien, Michael S Ewer, et al.
Pageof 34